Tampa, FL, United States of America

Brian Vesely

This inventor holds 2 USPTO granted patents. Top assignee: University of South Florida. Active years: 2017-2018.


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brian Vesely: Innovator in Antimicrobial and Anti-Leishmania Research

Introduction

Brian Vesely is a notable inventor based in Tampa, Florida. He has made significant contributions to the field of antimicrobial research and treatments for leishmaniasis. With a total of 2 patents, his work focuses on developing innovative solutions to combat infectious diseases.

Latest Patents

Vesely's latest patents include "Diterpenoid membranolide compounds having anti-leishmania activity and uses thereof." This invention emerged from a screening program that identified diterpenoid secondary metabolites produced by Antarctic sponges, which exhibit activity against the leishmaniasis-causing parasite. The patent outlines compositions useful for controlling these parasites both in vitro and in vivo, as well as methods for treating leishmaniasis. Another significant patent is titled "Antimicrobial compositions, methods of use, and methods of treatment of infections." This disclosure provides various compositions, including pharmaceutical formulations, aimed at treating infections and diseases.

Career Highlights

Brian Vesely is affiliated with the University of South Florida, where he conducts his research and development work. His innovative contributions have positioned him as a key figure in the field of antimicrobial research.

Collaborations

Throughout his career, Vesely has collaborated with esteemed colleagues, including Dennis Edward Kyle and Bill J Baker. These partnerships have enhanced the scope and impact of his research.

Conclusion

Brian Vesely's work in antimicrobial and anti-leishmania research exemplifies the importance of innovation in addressing public health challenges. His patents reflect a commitment to developing effective treatments for infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…